On the other hand, the impact of Tetherin was not observed until after 8 weeks following pathogenic LP-BM5 infection, a timepoint when IFN-α was induced, but fits within the chronic stage of infection and adaptive immune responses. This evidence concerns the gene BST2 and infection.